A multiadjuvant polysaccharide-amino acid-lipid (PAL) subunit nanovaccine generates robust systemic and lung-specific mucosal immune responses against SARS-CoV-2 in mice
B. Pandey, Z. Wang, A. Jimenez, E. Bhatia, R. Jain, A. Beach, D. Maniar, J. Hosten, L. O'Farrell, C. Vantucci, D. Hur, R. K. Noel, R. M. Ringquist, C. Smith, M. A. Ochoa, K. Roy
This study develops a mucosal nanovaccine that enhances both systemic and lung-specific immunity against SARS-CoV-2 in mice through intranasal and intramuscular delivery.
bioRxiv · May 5, 2023 · PreprintBioengineering